Abstract |
This study applied a linear discriminant analysis model to evaluate the performance of 2 types of commercially available extractable nuclear antigen (ENA) immunoassays for the screening and diagnosis of systemic autoimmune rheumatic diseases (SARDs) in a large tertiary hospital reference laboratory: (1) an enzyme-linked immunosorbent assay (ELISA) and (2) a multiplex bead-based immunoassay (MPBI). The results of the study showed both ENA immunoassays had comparable sensitivity for the detection of SARDs compared with the antinuclear antigen immunofluorescence (ANA-IF) method (ANA-IF: 85.6%, ENA-ELISA: 91.5%, ENA-MPBI: 83.1%, pairwise comparisons with ANA-IF: P > .05). However, both ENA immunoassays offered improved specificity compared with the ANA-IF (ANA-IF: 24.2%; ENA-ELISA: 39.8%; ENA-MPBI: 53.1%; pairwise comparison with ANA-IF: P < .001). The use of a more specific screening immunoassay with comparable sensitivity to ANA-IF is important in a tertiary hospital with high prevalence of non-SARD immune diseases. Diagnostic performance of the ENA/dsDNA components by the MPBI and ELISA methods did not differ significantly (area under the curve [AUC], 81.0% vs 83.0%, respectively, P > .05), but the key ENA/dsDNA variables contributing to the discriminating power of the assays for the diagnosis of specific SARDs were reagent/method dependent.
|
Authors | David Pi, Monika Hudoba de Badyn, Mike Nimmo, Rick White, Jason Pal, Patrick Wong, Carmen Phoon, Deidre O'Connor, Steven Pi, Kam Shojania |
Journal | American journal of clinical pathology
(Am J Clin Pathol)
Vol. 138
Issue 4
Pg. 596-603
(Oct 2012)
ISSN: 1943-7722 [Electronic] England |
PMID | 23010715
(Publication Type: Comparative Study, Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, Nuclear
- Autoantibodies
- Reagent Kits, Diagnostic
|
Topics |
- Antigens, Nuclear
(immunology)
- Autoantibodies
- Autoimmune Diseases
(diagnosis, immunology)
- Discriminant Analysis
- Enzyme-Linked Immunosorbent Assay
- Humans
- Immunoassay
- Mass Screening
- Microspheres
- Reagent Kits, Diagnostic
- Rheumatic Diseases
(diagnosis, immunology)
- Sensitivity and Specificity
- Tertiary Care Centers
|